Chennai volunteer’s illness not due to COVISHIELD vaccine dose, clarifies SII


Team Udayavani, Dec 1, 2020, 3:57 PM IST

New Delhi: Vaccine major Serum Institute of India on Tuesday clarified that the illness referred by a Chennai-based volunteer was “in no way induced by the vaccine”.

“The COVISHIELD vaccine is safe and immunogenic. The incident with the Chennai volunteer though highly unfortunate was in no way induced by the vaccine and Serum Institute of India is sympathetic with the volunteer’s medical condition,” read a statement issued by the Pune-based vaccine maker.

“However, we would like to clarify that all the requisite regulatory and ethical processes and guidelines were followed diligently and strictly. The concerned authorities were informed and the Principal Investigator, DSMB and the Ethics Committee independently cleared and reckoned it as a non-related issue to the vaccine trial,” the statement added.

A 40-year-old Chennai-based business consultant, who was a volunteer for the third phase of the vaccine trial conducted by Serum Institute of India (SII), has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to SII and others, besides seeking a halt to the trial.

He was administered the shot at Chennai’s Sri Ramachandra Institute of Higher Education and Research (SRIHER), one of the trial sites.

Rejecting the charges that AstraZeneca-Oxford’s COVID-19 vaccine candidate has serious side effects, Serum Institute on Sunday said that the volunteer is falsely laying the blame for his medical problems on the COVID vaccine trial and it will seek damages in excess of Rs 100 crore for “malicious” allegations.

“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer”s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer,” Serum Institute of India said in a statement.

“The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent. In-spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company,” Serum Institute said.

It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive, it added.

“The Serum Institute of India, will seek damages in excess of (Rs) 100 crore for the same and will defend such malicious claims,” the statement said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

BJP stages protest against Karnataka govt over Waqf properties row

Youth attempts suicide after being humiliated in public for wearing ripped jeans in Belthangady

India crawl to 51 for 4 after losing top-order

Nursing student suicide: Three students arrested in Kerala

Nadda’s letter to Kharge full of falsehoods: Cong

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Related Articles More

UP man gets 10-yr jail term for murder attempt on father

SC notice to Gujarat govt on Asaram’s plea seeking suspension of sentence in 2013 rape case

US charges against Adani, 7 others could lead to arrest warrants, extradition bid: attorney

Kerala HC denies bail to police officer accused of ‘raping’ minor Dalit girl

Nursing student suicide: Three students arrested in Kerala

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

UP man gets 10-yr jail term for murder attempt on father

Cement mixer truck overturns near Ambagilu

SC notice to Gujarat govt on Asaram’s plea seeking suspension of sentence in 2013 rape case

BJP stages protest against Karnataka govt over Waqf properties row

US charges against Adani, 7 others could lead to arrest warrants, extradition bid: attorney

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.